Shares of Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.55 and traded as high as $0.57. Elite Pharmaceuticals shares last traded at $0.57, with a volume of 916,561 shares trading hands.
Elite Pharmaceuticals Stock Down 3.6 %
The company has a debt-to-equity ratio of 0.10, a current ratio of 3.52 and a quick ratio of 2.42. The firm has a market capitalization of $587.23 million, a price-to-earnings ratio of -54.97 and a beta of 0.25. The business has a fifty day moving average price of $0.55 and a two-hundred day moving average price of $0.35.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Articles
- Five stocks we like better than Elite Pharmaceuticals
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Ride Out The Recession With These Dividend Kings
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Profitably Trade Stocks at 52-Week Highs
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
